跳至主要内容
临床试验/CTRI/2021/01/030575
CTRI/2021/01/030575尚未招募未知

â??Evaluation of Compliance in Hormone Receptor Positive Early (non-metastatic) Breast CancerPatients receiving hormonal therapy from a Tertiary Care Cancer Centerâ??.

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •1) Patients with histologically confirmed non-metastatic breast cancer
  • •2) Hormone receptor (HR) positive (defined as at-least 1% cells positive for either ER or PR or both) and
  • •3) Who will be attending the breast OPDâ??s of any discipline during the study period irrespective of their registration date to Tata Memorial Centre.
  • •4) Patients on treatment with endocrine therapy who had completed at least 6 months of treatment (this corresponds to one prescription fill).

排除标准

  • •1) Non-Indianpatients
  • •2) Metastatic disease
  • •3) Not received cancer-directed surgery
  • •4) Those patients who have not completed at-least 6 months of endocrine therapy
  • •5) Had experienced recurrence prior to the 2-year follow-up survey (For only prospective cohort)

研究者

相似试验